290 related articles for article (PubMed ID: 26671124)
1. Dysferlinopathy in Iran: Clinical and genetic report.
Fatehi F; Nafissi S; Urtizberea JA; Blanck-Labelle V; Lévy N; Krahn M; Dbouk MB; Attarian S
J Neurol Sci; 2015 Dec; 359(1-2):256-9. PubMed ID: 26671124
[TBL] [Abstract][Full Text] [Related]
2. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
3. Late onset in dysferlinopathy widens the clinical spectrum.
Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
5. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
6. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
8. Challenges for the genetic screening in dysferlin deficiency--report of an instructive case and review of the literature.
Gal A; Siska E; Nagy Z; Karpati G; Molnar MJ
Clin Neuropathol; 2008; 27(5):289-94. PubMed ID: 18808059
[TBL] [Abstract][Full Text] [Related]
9. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
10. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
[TBL] [Abstract][Full Text] [Related]
11. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
[TBL] [Abstract][Full Text] [Related]
12. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
[TBL] [Abstract][Full Text] [Related]
13. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of 112 Iranian patients and reporting of a possible founder effect.
Mojbafan M; Bahmani R; Bagheri SD; Sharifi Z; Zeinali S
Orphanet J Rare Dis; 2020 Jan; 15(1):14. PubMed ID: 31937337
[TBL] [Abstract][Full Text] [Related]
15. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous characteristics of Korean patients with dysferlinopathy.
Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
[TBL] [Abstract][Full Text] [Related]
17. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy.
Park YE; Kim HS; Lee CH; Nam TS; Choi YC; Kim DS
Neuromuscul Disord; 2012 Jun; 22(6):505-10. PubMed ID: 22297152
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel heterozygous DYSF variant in a large family with a dominantly-inherited dysferlinopathy.
Folland C; Johnsen R; Botero Gomez A; Trajanoski D; Davis MR; Moore U; Straub V; Barresi R; Guglieri M; Hayhurst H; Schaefer AM; Laing NG; Lamont PJ; Ravenscroft G
Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12846. PubMed ID: 35962550
[TBL] [Abstract][Full Text] [Related]
20. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.
Xi J; Blandin G; Lu J; Luo S; Zhu W; Béroud C; Pécheux C; Labelle V; Lévy N; Urtizberea JA; Zhao C; Krahn M
Neurol India; 2014; 62(6):635-9. PubMed ID: 25591676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
